Thoratec was a surprise however the lack of any spike and a -5-10% drop is unwarranted. Again we seem content to fall on any positve news and hit the ground with bad news. Problem is shorts are less than 10% of total o/s. The real worry is the lack of buying even at these lows. 5 months ago we touched 7 now were at 2. Europe has been slow an average of 1-3 implants per quarter isnt progress. Need a turnaround fast.
Having thoratec as the seat observer doesnt mean they are the only interested party.
Most of us have been in denial for a while now but this has been very dissappointing.Hoping for the best but dilution at this range will be very bad.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
